News
Drug-cost disclosure hits obstacle
Pharmaceuticals and money -- elements in the debate over a cost-disclosure bill. (Photo: O.S. Fisher, Shutterstock)An attempt to force drug makers to disclose their costs and profits for drugs that sell wholesale for more than $10,000 annually was derailed in the Legislature, facing strong opposition from an industry targeting similar measures in other states. The forces battling over the bill include some of the most powerful in California.